170 related articles for article (PubMed ID: 1327071)
41. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
[TBL] [Abstract][Full Text] [Related]
42. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin.
Bondioni S; Mantovani G; Polentarutti N; Ambrosi B; Loli P; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
J Endocrinol Invest; 2007 Nov; 30(10):828-32. PubMed ID: 18075284
[TBL] [Abstract][Full Text] [Related]
44. Proopiomelanocortin-derived peptides.
Bertagna X
Endocrinol Metab Clin North Am; 1994 Sep; 23(3):467-85. PubMed ID: 7805649
[TBL] [Abstract][Full Text] [Related]
45. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
Orth DN; Peterson ME; Drucker WD
Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
[TBL] [Abstract][Full Text] [Related]
46. Alpha-amidated peptides derived from pro-opiomelanocortin in human pituitary tumours.
Fenger M; Johnsen AH
J Endocrinol; 1988 Aug; 118(2):329-38. PubMed ID: 2844950
[TBL] [Abstract][Full Text] [Related]
47. Plasma immunoreactive joining peptide in man: a new marker of proopiomelanocortin processing and corticotroph function.
Phlipponneau M; Lenne F; Proeschel MF; Girard F; Luton JP; Bertagna X
J Clin Endocrinol Metab; 1993 Feb; 76(2):325-9. PubMed ID: 8381797
[TBL] [Abstract][Full Text] [Related]
48. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M
Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445
[TBL] [Abstract][Full Text] [Related]
49. Ectopic secretion of peptides of the proopiomelanocortin family.
Schteingart DE
Endocrinol Metab Clin North Am; 1991 Sep; 20(3):453-71. PubMed ID: 1657597
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
[TBL] [Abstract][Full Text] [Related]
51. Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsiveness.
Pecori Giraldi F; Marini E; Torchiana E; Mortini P; Dubini A; Cavagnini F
J Endocrinol; 2003 Jun; 177(3):373-9. PubMed ID: 12773117
[TBL] [Abstract][Full Text] [Related]
52. Adrenocorticotropic hormone and beta-endorphin concentrations in the inferior petrosal sinuses in Cushing's disease and other pituitary diseases.
Colao A; Merola B; Spaziante R; La Tessa G; Boudouresque F; Oliver C; Lombardi G
J Endocrinol Invest; 1992 Dec; 15(11):807-13. PubMed ID: 1337906
[TBL] [Abstract][Full Text] [Related]
53. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
[TBL] [Abstract][Full Text] [Related]
54. Structure of the POMC promoter region in pituitary and extrapituitary ACTH producing tumors.
Mönig H; Ali IU; Oldfield EH; Schulte HM
Exp Clin Endocrinol; 1993; 101(1):36-8. PubMed ID: 8386673
[TBL] [Abstract][Full Text] [Related]
55. Adrenocortical-pituitary hybrid tumor causing Cushing's syndrome.
Hiroi N; Chrousos GP; Kohn B; Lafferty A; Abu-Asab M; Bonat S; White A; Bornstein SR
J Clin Endocrinol Metab; 2001 Jun; 86(6):2631-7. PubMed ID: 11397864
[TBL] [Abstract][Full Text] [Related]
56. Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence.
Rees DA; Hepburn PJ; McNicol AM; Francis K; Jasani B; Lewis MD; Farrell WE; Lewis BM; Scanlon MF; Ham J
Mol Cell Endocrinol; 2002 Mar; 189(1-2):51-7. PubMed ID: 12039064
[TBL] [Abstract][Full Text] [Related]
57. In vitro secretion of adenoma and anterior lobe cells in two typical cases of Cushing's disease.
Lüdecke DK; Schabet M; Saeger W
Neurosurgery; 1983 May; 12(5):549-54. PubMed ID: 6306501
[TBL] [Abstract][Full Text] [Related]
58. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
Nakashima H; Hirata Y; Uchihashi M; Tomita M; Fujita T
Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease.
Iino K; Oki Y; Matsushita F; Yamashita M; Hayashi C; Miura K; Nishizawa S; Nakamura H
Pituitary; 2007; 10(1):35-45. PubMed ID: 17410413
[TBL] [Abstract][Full Text] [Related]
60. Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Cuneo RC; Lee W; Harper J; Mitchell K; Ward G; Atkinson RL; Salkield I; Cameron DP
Clin Endocrinol (Oxf); 1997 May; 46(5):607-18. PubMed ID: 9231057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
